(3β,25R)-Spirost-5-en-3-ol – (512-04-9)

Tiratricol, 51-24-1, 3, 3', 5-TRIIODOTHYROACETIC ACID, Triac, Triiodothyroacetic acid, Teatrois, Tiratricolum, Tiracana, 2-[4-(4-hydroxy-3-iodophenoxy)-3, 5-diiodophenyl]acetic acid, Tiratricol [INN], T3-acetic acid, 3', 3, 5-Triiodothyroacetic acid, Tiratricolum [INN-Latin], 3, 3', 5-Triiodo Thyroacetic Acid, UNII-29OQ9EU4R1, 3, 5, 3'-triiodothyroacetate, Tiracana (TN), Tiratricol (INN), NSC-759294, 2-(4-(4-hydroxy-3-iodophenoxy)-3, 5-diiodophenyl)acetic acid, Benzeneacetic acid, 4-(4-hydroxy-3-iodophenoxy)-3, 5-diiodo-, DTXSID2045232, TIRATRICOL [MI], EINECS 200-086-1, MFCD00055931, TIRATRICOL [MART.], TIRATRICOL [WHO-DD], CHEMBL41632, 29OQ9EU4R1, 4-(4-Hydroxy-3-iodophenoxy)-3, 5-diiodobenzeneacetic acid, DTXCID0025232, Triacana, [4-(4-HYDROXY-3-IODO-PHENOXY)-3, 5-DIIODO-PHENYL]-ACETIC ACID, NSC 759294, T3-ACETIC ACID [USP IMPURITY], CAS-51-24-1, NCGC00016227-01, (4-(4-Hydroxy-3-iodophenoxy)-3, 5-diiodophenyl)acetic acid, [4-(4-hydroxy-3-iodophenoxy)-3, 5-diiodophenyl]acetic acid, Tiratricol, 3, 3', 5-triiodothyroacetic acid, Tiratricolum (INN-Latin), TRIIODOTHYROACETIC ACID [USP IMPURITY], TIRATRICOL (MART.), LEVOTHYROXINE SODIUM IMPURITY C [EP IMPURITY], LIOTHYRONINE SODIUM IMPURITY C [EP IMPURITY], Levothyroxine sodium impurity, triiodothyroacetic acid, or t3-acetic acid-, T3-ACETIC ACID (USP IMPURITY), [4-(4-Hydroxy-3-iodophenoxy)-3, 5-diiodophenyl]acetic Acid (Triiodothyroacetic Acid), 4HY, SMR000058684, TRIIODOTHYROACETIC ACID (USP IMPURITY), SR-01000003135, LIOTHYRONINE SODIUM IMPURITY C (EP IMPURITY), LEVOTHYROXINE SODIUM IMPURITY C (EP IMPURITY), Emcitate, Nidolin, Triax, TAatrois, (4-(4-Hydroxy-3-Iodo-Phenoxy)-3, 5-Diiodo-Phenyl)-Acetic Acid, 3, 5, 3'-triiodothyroacetic acid, LEVOTHYROXINE SODIUM IMPURITY, TRIIODOTHYROACETIC ACID, OR T3-ACETIC ACID-(USP IMPURITY), LEVOTHYROXINE SODIUM IMPURITY, TRIIODOTHYROACETIC ACID, OR T3-ACETIC ACID-[USP IMPURITY], Prestwick_439, Tiratricol (Standard), 3, 5-diiodo-3'-isopropylthyroacetic acid, 1nq0, 2-[4-(4-hydroxy-3-iodo-phenoxy)-3, 5-diiodo-phenyl]acetic acid, Prestwick0_000202, Prestwick1_000202, Prestwick2_000202, Prestwick3_000202, Triiodothyroacetic acid, 3, REGID_for_CID_5803, SCHEMBL25149, BSPBio_000183, MLS000028613, MLS006010657, SPBio_002104, 3, 3, 5-triiodothyroacetic acid, BPBio1_000203, GTPL2637, 3, 5, 39-triiodothyroacetic acid, BDBM18862, CHEBI:40021, HY-B1201R, 4-(4-Hydroxy-3-iodophenoxy)-3, 5-diiodophenylacetic acid, D11AX08, H03AA04, UOWZUVNAGUAEQC-UHFFFAOYSA-N, HMS1568J05, HMS2095J05, HMS3264A05, HMS3652J07, HMS3712J05, Pharmakon1600-01506047, BCP07182, HY-B1201, Tox21_110317, Tox21_303544, NSC759294, s4185, AKOS015951178, CCG-213970, CS-4829, DB03604, FT28502, NCGC00016227-02, NCGC00016227-03, NCGC00016227-04, NCGC00016227-05, NCGC00016227-06, NCGC00016227-07, NCGC00016227-08, NCGC00257371-01, AS-15930, DA-58599, 3, 3', 5-Triiodothyroacetic acid, >=90%, SBI-0207015.P001, 3, 3', 5-Triiodothyroacetic acid, free acid, NS00015686, SW196661-4, T3878, D07214, LEVOTHYROXINE SODIUM IMPURITY [USP IMPURITY], Q7809151, SR-01000003135-2, SR-01000003135-3, BRD-K61236135-001-03-3, BRD-K61236135-001-08-2, BRD-K61236135-001-09-0, 3, 3 inverted exclamation marka, 5-Triiodothyroacetic acid, [(4-hydroxy-3-iodo-4-phenoxy)-3, 5-diiodophenyl]acetic acid, 2-(4-(4-hydroxy-3-iodophenoxy)-3, 5-diiodophenyl)aceticacid, 4-(4-Hydroxy-3-iodophenoxy)-3, 5-diiodobenzeneacetic acid Nidolin T3A Tiratricol, 200-086-1